SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038739
Filing Date
2023-08-07
Accepted
2023-08-07 07:20:50
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-20230630.htm   iXBRL 10-Q 3702973
2 EX-10.1 sage-ex10_1.htm EX-10.1 63454
3 EX-10.2 sage-ex10_2.htm EX-10.2 347751
4 EX-10.3 sage-ex10_3.htm EX-10.3 84799
5 EX-10.4 sage-ex10_4.htm EX-10.4 485675
6 EX-10.5 sage-ex10_5.htm EX-10.5 288796
7 EX-10.6 sage-ex10_6.htm EX-10.6 372757
8 EX-31.1 sage-ex31_1.htm EX-31.1 13990
9 EX-31.2 sage-ex31_2.htm EX-31.2 13969
10 EX-32.1 sage-ex32_1.htm EX-32.1 13012
11 GRAPHIC img93201763_0.jpg GRAPHIC 159175
  Complete submission text file 0000950170-23-038739.txt   14684450

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sage-20230630_lab.xml EX-101.LAB 418705
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sage-20230630_pre.xml EX-101.PRE 323151
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sage-20230630_def.xml EX-101.DEF 233363
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sage-20230630.xsd EX-101.SCH 49705
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sage-20230630_cal.xml EX-101.CAL 42439
58 EXTRACTED XBRL INSTANCE DOCUMENT sage-20230630_htm.xml XML 2848804
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 231145577
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences